LIFESCIENCE TECHNOLOGY LIMITED

Company Registration Number:
SC770575 (Scotland)

Unaudited abridged accounts for the year ended 31 May 2024

Period of accounts

Start date: 24 May 2023

End date: 31 May 2024

LIFESCIENCE TECHNOLOGY LIMITED

Contents of the Financial Statements

for the Period Ended 31 May 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Balance sheet notes - 11

LIFESCIENCE TECHNOLOGY LIMITED

Company Information

for the Period Ended 31 May 2024




Director: Neil Gordon MacRae
Registered office: Suite 50, Pure Offices
Suite 50, Pure Offices
4-5 Lochside Way, Edinburgh Park
Edinburgh
GB-SCT
EH12 9DT
Company Registration Number: SC770575 (Scotland)

LIFESCIENCE TECHNOLOGY LIMITED

Directors' Report Period Ended 31 May 2024

The directors present their report with the financial statements of the company for the period ended 31 May 2024

Directors

The director(s) shown below were appointed to the company during the period
Neil Gordon MacRae
24 May 2023

This report was approved by the board of directors on 4 March 2025
And Signed On Behalf Of The Board By:

Name: Neil Gordon MacRae
Status: Director

LIFESCIENCE TECHNOLOGY LIMITED

Profit and Loss Account

for the Period Ended 31 May 2024


Notes

2024
£
Gross Profit or (Loss) 559,108
Income from coronavirus (COVID-19) business support grants 0
Distribution Costs ( 0 )
Administrative Expenses ( 526,245 )
Operating Profit or (Loss) 32,863
Profit or (Loss) Before Tax 32,863
Profit or (Loss) for Period 32,863

The notes form part of these financial statements

LIFESCIENCE TECHNOLOGY LIMITED

Balance sheet

As at 31 May 2024


Notes

2024
£
Fixed assets
Tangible assets: 4 16,110
Total fixed assets: 16,110
Current assets
Debtors: 191,085
Cash at bank and in hand: 68,601
Total current assets: 259,686
Creditors: amounts falling due within one year: ( 242,633 )
Net current assets (liabilities): 17,053
Total assets less current liabilities: 33,163
Total net assets (liabilities): 33,163

The notes form part of these financial statements

LIFESCIENCE TECHNOLOGY LIMITED

Balance sheet continued

As at 31 May 2024


Notes

2024
£
Capital and reserves
Called up share capital: 300
Profit and loss account: 32,863
Shareholders funds: 33,163

For the year ending 31 May 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 4 March 2025
And Signed On Behalf Of The Board By:

Name: Neil Gordon MacRae
Status: Director

The notes form part of these financial statements

LIFESCIENCE TECHNOLOGY LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

LIFESCIENCE TECHNOLOGY LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2024

  • 2. Employees


    2024
    Average number of employees during the period 4

LIFESCIENCE TECHNOLOGY LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2024

  • 3. Off balance sheet disclosure

    No

LIFESCIENCE TECHNOLOGY LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2024

4. Tangible Assets

Total
Cost £
Additions 16,110
Disposals -
Revaluations -
Transfers -
At 31 May 2024 16,110
Depreciation
Charge for year -
On disposals -
Other adjustments -
At 31 May 2024 -
Net book value
At 31 May 2024 16,110